(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

MACFARLAN SMITH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

MACFARLAN SMITH

ST13

US500000079042398

Class

1, 5, 40, 42

Filing

79042398

Registration

3647632

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

66

Latest update

11/19/2023

Trademark type

Combined

Nice classes

1, 5, 40, 42

Filing date

06/21/2007

Registration date

06/30/2009

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2020

Last transaction

02/18/2020

Responsible office

United States Patent and Trademark Office

Status code

706

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

GB

Examiner

PERKINS, ELLEN

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Macfarlan Smith Limited
Johnson Matthey Public Limited Company

Representatives

A TALLY EITAN Eitan Mehulal Sadot

Technical classification

Nice Classes

Class 1Class 5Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemical compounds for use in the manufacture of pharmaceuticals; chemicals for use as active pharmaceutical ingredients; chemical preparations and substances used to denaturise other chemical substances by rendering them unsuitable for human and animal consumption

Class 5

Pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for use as pain relief medication; pharmaceutical preparationsopiates and opioids

Class 40

Custom manufacture of pharmaceuticals and active pharmaceutical ingredients

Class 42

Research and development of pharmaceuticals and active pharmaceutical ingredients

Publications

History of USPTO decisions and trademark events.

66 publications found

CHLD

CHANGE OF OWNER RECEIVED FROM IB

11/19/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/18/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/18/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/18/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/18/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/18/2020

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

02/18/2020

71AG

REGISTERED-SEC.71 ACCEPTED

02/18/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

02/18/2020

PR71

POST REGISTRATION ACTION MAILED - SEC.71

02/13/2020

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

02/03/2020

PR71

POST REGISTRATION ACTION MAILED - SEC.71

09/09/2019

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/09/2019

ES71

TEAS SECTION 71 RECEIVED

06/25/2019

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

06/30/2018

RNWL

INTERNATIONAL REGISTRATION RENEWED

08/03/2017

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/30/2017

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

11/15/2016

C75A

REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.

11/15/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

11/14/2016

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

07/22/2016

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

01/28/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/21/2016

ES75

TEAS SECTION 71 & 15 RECEIVED

12/21/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

01/27/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/07/2009

FIMP

FINAL DISPOSITION PROCESSED

10/07/2009

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/30/2009

R.PR

REGISTERED-PRINCIPAL REGISTER

06/30/2009

PUBO

PUBLISHED FOR OPPOSITION

04/14/2009

NPUB

NOTICE OF PUBLICATION

03/25/2009

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

03/13/2009

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/06/2009

ALIE

ASSIGNED TO LIE

03/06/2009

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/04/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/04/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/04/2009

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/04/2009

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/26/2009

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

02/26/2009

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

09/10/2008

GNFR

FINAL REFUSAL E-MAILED

09/10/2008

CNFR

FINAL REFUSAL WRITTEN

09/10/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/28/2008

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/28/2008

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/28/2008

DOCK

ASSIGNED TO EXAMINER

05/05/2008

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

03/11/2008

GPRA

PRIORITY ACTION E-MAILED

03/11/2008

CPRA

PRIORITY ACTION WRITTEN

03/11/2008

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/21/2007

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2007

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/21/2007

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/18/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/18/2007

RFNP

REFUSAL PROCESSED BY IB

10/26/2007

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/02/2007

RFRR

REFUSAL PROCESSED BY MPU

10/02/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/02/2007

CNRT

NON-FINAL ACTION WRITTEN

10/01/2007

RFWR

NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW

09/25/2007

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/25/2007

CNRT

NON-FINAL ACTION WRITTEN

09/24/2007

DOCK

ASSIGNED TO EXAMINER

09/24/2007

NWAP

NEW APPLICATION ENTERED

09/21/2007

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/20/2007

Continuous trademark protection

Get notified about every new filing that threatens MACFARLAN SMITH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.